Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Effectiveness of Heart Failure Checklist Management in Patients with Chronic Heart Failure: An Open-Label, Single-Center Controlled Study During 18 Months of Follow-UpTherapeutics and clinical risk management, 2023-11, Vol.19, p.983-992 [Peer Reviewed Journal]COPYRIGHT 2023 Dove Medical Press Limited ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S417426Full text available |
|
2 |
Material Type: Article
|
Astragaloside IV alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathwayPharmaceutical biology, 2019-01, Vol.57 (1), p.48-54 [Peer Reviewed Journal]2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2019 ;2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2019 The Author(s) ;ISSN: 1388-0209 ;EISSN: 1744-5116 ;DOI: 10.1080/13880209.2019.1569697 ;PMID: 30905241Full text available |
|
3 |
Material Type: Article
|
The association between COPD and heart failure risk: a reviewInternational journal of chronic obstructive pulmonary disease, 2013-01, Vol.8 (default), p.305-312 [Peer Reviewed Journal]COPYRIGHT 2013 Dove Medical Press Limited ;COPYRIGHT 2013 Dove Medical Press Limited ;2013 De Miguel Díez et al, publisher and licensee Dove Medical Press Ltd 2013 ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/copd.s31236 ;PMID: 23847414Full text available |
|
4 |
Material Type: Article
|
Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure ratsPharmaceutical biology, 2020-01, Vol.58 (1), p.417-426 [Peer Reviewed Journal]2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 The Author(s) ;ISSN: 1388-0209 ;EISSN: 1744-5116 ;DOI: 10.1080/13880209.2020.1761403 ;PMID: 32429724Full text available |
|
5 |
Material Type: Article
|
Patients with Heart Failure During and After Inpatient Cardiac RehabilitationVascular health and risk management, 2021-01, Vol.17, p.49-58 [Peer Reviewed Journal]2021 Schürmann et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Schürmann et al. 2021 Schürmann et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S276465 ;PMID: 33623387Full text available |
|
6 |
Material Type: Article
|
Heart failure with preserved ejection fraction: strategies for disease management and emerging therapeutic approachesPostgraduate medicine, 2021-02, Vol.133 (2), p.125-139 [Peer Reviewed Journal]2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;ISSN: 0032-5481 ;EISSN: 1941-9260 ;DOI: 10.1080/00325481.2020.1842620 ;PMID: 33283589Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
Heart failure with preserved ejection fraction: disease burden for patients, caregivers, and the health-care systemPostgraduate medicine, 2021-02, Vol.133 (2), p.140-145 [Peer Reviewed Journal]2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;ISSN: 0032-5481 ;EISSN: 1941-9260 ;DOI: 10.1080/00325481.2020.1842621 ;PMID: 33131371Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Targeting heart failure with preserved ejection fraction: current status and future prospectsVascular health and risk management, 2016-01, Vol.12 (Issue 1), p.129-141 [Peer Reviewed Journal]COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Kanwar et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S83662 ;PMID: 27143907Full text available |
|
9 |
Material Type: Article
|
Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary diseaseInternational journal of chronic obstructive pulmonary disease, 2015-01, Vol.10, p.515-523 [Peer Reviewed Journal]2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Kubota et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S79942 ;PMID: 25784798Full text available |
|
10 |
Material Type: Article
|
Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectivesVascular health and risk management, 2017-01, Vol.13, p.369-382 [Peer Reviewed Journal]COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Yandrapalli et al. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/vhrm.s114784 ;PMID: 29042791Full text available |
|
11 |
Material Type: Article
|
Symptoms and impact of symptoms on function and health in patients with chronic obstructive pulmonary disease and chronic heart failure in primary health careInternational journal of chronic obstructive pulmonary disease, 2014-01, Vol.9 (default), p.785-794 [Peer Reviewed Journal]COPYRIGHT 2014 Dove Medical Press Limited ;COPYRIGHT 2014 Dove Medical Press Limited ;2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Theander et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S62563 ;PMID: 25071370Full text available |
|
12 |
Material Type: Article
|
Platelet, Neutrophil and Lymphocyte Quantitative Abnormalities in Patients with Heart Failure: A Retrospective StudyVascular health and risk management, 2023-01, Vol.19, p.69-78 [Peer Reviewed Journal]2023 Getawa and Bayleyegn. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Getawa and Bayleyegn. 2023 Getawa and Bayleyegn. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S394765 ;PMID: 36776273Full text available |
|
13 |
Material Type: Article
|
Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartanVascular health and risk management, 2020-01, Vol.16, p.41-51 [Peer Reviewed Journal]2020 Sokos and Raina. ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Sokos and Raina. 2020 Sokos and Raina. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S197291 ;PMID: 32021227Full text available |
|
14 |
Material Type: Article
|
Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and PerspectivesVascular health and risk management, 2019-01, Vol.15, p.571-579 [Peer Reviewed Journal]2019 Manolis et al. ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Manolis et al. 2019 Manolis et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S210150 ;PMID: 31920323Full text available |
|
15 |
Material Type: Article
|
Paeonol attenuates heart failure induced by transverse aortic constriction via ERK1/2 signallingPharmaceutical biology, 2022-12, Vol.60 (1), p.562-569 [Peer Reviewed Journal]2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 The Author(s) ;ISSN: 1388-0209 ;EISSN: 1744-5116 ;DOI: 10.1080/13880209.2022.2040543 ;PMID: 35249458Full text available |
|
16 |
Material Type: Article
|
The impact of preoperative kidney replacement therapy on kidney outcome and survival in patients with left ventricular assist deviceRenal failure, 2023-12, Vol.45 (1), p.2157285-2157285 [Peer Reviewed Journal]2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 ;2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 The Author(s) ;ISSN: 0886-022X ;EISSN: 1525-6049 ;DOI: 10.1080/0886022X.2022.2157285 ;PMID: 36763000Full text available |
|
17 |
Material Type: Article
|
Pediatric ventricular assist devices: current challenges and future prospectsVascular health and risk management, 2017-01, Vol.13, p.177-185 [Peer Reviewed Journal]COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Burki and Adachi. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S82379 ;PMID: 28546755Full text available |
|
18 |
Material Type: Article
|
Machine learning model and nomogram to predict the risk of heart failure hospitalization in peritoneal dialysis patientsRenal failure, 2024-12, Vol.46 (1), p.2324071-2324071 [Peer Reviewed Journal]2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 0886-022X ;EISSN: 1525-6049 ;DOI: 10.1080/0886022X.2024.2324071 ;PMID: 38494197Full text available |
|
19 |
Material Type: Article
|
The causes, consequences, and treatment of left or right heart failureVascular health and risk management, 2011-01, Vol.7, p.237-254 [Peer Reviewed Journal]2011. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2011 Pazos-López et al, publisher and licensee Dove Medical Press Ltd. 2011 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S10669 ;PMID: 21603593Full text available |
|
20 |
Material Type: Article
|
B-Type Natriuretic Peptides (BNP) and Tissue Doppler E/e´ Before and After 4 Weeks Standard Treatment of African Heart Failure Subjects: The ABU-BNP Longitudinal SurveyVascular health and risk management, 2019-01, Vol.15, p.559-569 [Peer Reviewed Journal]2019 Onyemelukwe et al. ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Onyemelukwe et al. 2019 Onyemelukwe et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S211498 ;PMID: 31908467Full text available |